Longboard Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Joshua J. Dapice(9.99%),Philip D. Dreyfuss(9.99%), etc.
Longboard Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(8.3%)
Longboard Pharmaceuticals | 10-Q: Quarterly report
Longboard Pharmaceuticals | 8-K: Longboard Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Corporate Updates
Longboard Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(1.401%),Abigail P. Johnson(1.401%)
Longboard Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(11.182%),Abigail P. Johnson(11.182%)
Longboard Pharmaceuticals | SC TO-T/A: Third party tender offer statement (Amendment)
Longboard Pharmaceuticals | SC 14D9/A: Tender offer solicitation/recommendation statements filed under Rule 14d-9 (Amendment)
Longboard Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(5.22%)
Longboard Pharmaceuticals | SC 14D9: Tender offer solicitation/recommendation statements filed under Rule 14d-9
Longboard Pharmaceuticals | SC TO-T: Third party tender offer statement
Longboard Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Kaye Randall
Longboard Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Roberts Brandi
Longboard Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Lind Kevin Robert
Longboard Pharmaceuticals | SC TO-C: Written communication relating to an issuer or third party tender offer
Longboard Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(8.3%)
Longboard Pharmaceuticals | SC TO-C: Written communication relating to an issuer or third party tender offer
Longboard Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Kaye Randall
Longboard Pharmaceuticals | SC14D9C: Written communication by the subject company relating to a third party tender offer
Longboard Pharmaceuticals | SC TO-C: Written communication relating to an issuer or third party tender offer
No Data
No Data